Vyvanse and Sennosides drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vyvanse (lisdexamfetamine dimesylate) and Sennosides (senna). Common drug interactions include somnolence among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Vyvanse and Sennosides. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Vyvanse?

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,870 Vyvanse users. Check the latest studies of Vyvanse.

What is Sennosides?

Sennosides has active ingredients of senna. It is often used in constipation. eHealthMe is studying from 8,247 Sennosides users. Check the latest studies of Sennosides.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 29, 2026

23 people who take Vyvanse and Sennosides together, and have interactions are studied.

Vyvanse and Sennosides drug interactions.

What are the common drug interactions of Vyvanse and Sennosides, by gender? *:

female:

  1. Somnolence (a state of near-sleep, a strong desire for sleep)
  2. Pathological fracture (broken bone caused by disease)
  3. Vision blurred
  4. Visual impairment
  5. Weight increased
  6. Nausea (feeling of having an urge to vomit)
  7. Reading disorder (problem in areas of the brain that help interpret language)
  8. Acne (skin problems that cause pimples)
  9. Adverse drug reaction
  10. Aggression

male:

  1. Febrile neutropenia (fever with reduced white blood cells)

What are the common drug interactions of Vyvanse and Sennosides, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Disturbance in attention
  2. Drug intolerance (drug sensitivity)
  3. Fluid retention (an abnormal accumulation of fluid in the blood)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Acne (skin problems that cause pimples)
  6. Adverse drug reaction
  7. Aggression
  8. Depressive symptom
  9. Drug ineffective
  10. Fatigue (feeling of tiredness)

30-39:

  1. Arthralgia (joint pain)
  2. Cellulitis (infection under the skin)
  3. Dizziness
  4. Drug level decreased
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Gingivitis (inflammation of gums)
  7. Hot flush (sudden feelings of heat)
  8. Infusion related reaction
  9. Nausea (feeling of having an urge to vomit)
  10. Nephrolithiasis (calculi in the kidneys)

40-49:

  1. Nausea (feeling of having an urge to vomit)
  2. Oral pain
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Platelet count decreased

50-59:

n/a

60+:

  1. Ankle fracture
  2. Diplopia (double vision)
  3. Blood iron decreased
  4. Ear infection
  5. Haematocrit decreased
  6. Haemoglobin decreased
  7. Protein total decreased
  8. Red blood cell count decreased
  9. Fall
  10. Electrocardiogram qt prolonged

What are the existing conditions these people have? *

  1. High Blood Pressure: 6 people, 26.09%
  2. Bipolar Disorder (mood disorder): 6 people, 26.09%
  3. Osteopenia (a condition where bone mineral density is lower than normal): 6 people, 26.09%
  4. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 6 people, 26.09%
  5. Itching: 6 people, 26.09%
  6. Irritable Bowel Syndrome: 6 people, 26.09%
  7. Restless Leg Syndrome (a powerful urge to move your legs): 6 people, 26.09%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 26.09%
  9. Binge Eating (pattern of disordered eating which consists of episodes of uncontrollable eating): 6 people, 26.09%
  10. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 21.74%

* Approximation only. Some reports may have incomplete information.

Do you take Vyvanse and Sennosides?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vyvanse and Sennosides:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vyvanse:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sennosides:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vyvanse and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sennosides and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lisdexamfetamine dimesylate and senna (the active ingredients of Vyvanse and Sennosides, respectively), and Vyvanse and Sennosides (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: